267 related articles for article (PubMed ID: 30936378)
1. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract][Full Text] [Related]
3. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Xie M; Gao J; Ma X; Song J; Wu C; Zhou Y; Jiang T; Liang Y; Yang C; Bao X; Zhang X; Yao J; Jing Y; Wu J; Wang J; Xue X
BMC Cancer; 2024 Mar; 24(1):372. PubMed ID: 38528507
[TBL] [Abstract][Full Text] [Related]
4. Computed Tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma.
Shang Y; Chen W; Li G; Huang Y; Wang Y; Kui X; Li M; Zheng H; Zhao W; Liu J
Radiol Med; 2023 Dec; 128(12):1483-1496. PubMed ID: 37749461
[TBL] [Abstract][Full Text] [Related]
5. A CT-based radiomics nomogram for prediction of lung adenocarcinomas and granulomatous lesions in patient with solitary sub-centimeter solid nodules.
Chen X; Feng B; Chen Y; Liu K; Li K; Duan X; Hao Y; Cui E; Liu Z; Zhang C; Long W; Liu X
Cancer Imaging; 2020 Jul; 20(1):45. PubMed ID: 32641166
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a preoperative CT‑based radiomics nomogram to differentiate tuberculosis granulomas from lung adenocarcinomas: an external validation study.
Yang L; Jiang Z; Tong J; Li N; Dong Q; Wang K
BMC Cancer; 2024 Jun; 24(1):670. PubMed ID: 38824514
[TBL] [Abstract][Full Text] [Related]
7. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Qi H; Hou Y; Zheng Z; Zheng M; Qiao Q; Wang Z; Sun X; Xing L
BMC Cancer; 2024 Mar; 24(1):362. PubMed ID: 38515096
[TBL] [Abstract][Full Text] [Related]
9. Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma.
Shi Z; Zheng X; Shi R; Song C; Yang R; Zhang Q; Wang X; Lu J; Yu Y; Liu Q; Jiang T
Sci Rep; 2017 Mar; 7(1):364. PubMed ID: 28336963
[TBL] [Abstract][Full Text] [Related]
10. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
[TBL] [Abstract][Full Text] [Related]
11. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
[No Abstract] [Full Text] [Related]
12. Development and Validation of a Deep Learning Radiomics Model to Predict High-Risk Pathologic Pulmonary Nodules Using Preoperative Computed Tomography.
Ye G; Wu G; Li K; Zhang C; Zhuang Y; Liu H; Song E; Qi Y; Li Y; Yang F; Liao Y
Acad Radiol; 2024 Apr; 31(4):1686-1697. PubMed ID: 37802672
[TBL] [Abstract][Full Text] [Related]
13. Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Digumarthy SR; Padole AM; Gullo RL; Sequist LV; Kalra MK
Medicine (Baltimore); 2019 Jan; 98(1):e13963. PubMed ID: 30608433
[TBL] [Abstract][Full Text] [Related]
14. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
Xing X; Li L; Sun M; Zhu X; Feng Y
Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
[TBL] [Abstract][Full Text] [Related]
15. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract][Full Text] [Related]
16. EfficientNet-Based System for Detecting EGFR-Mutant Status and Predicting Prognosis of Tyrosine Kinase Inhibitors in Patients with NSCLC.
Xu N; Wang J; Dai G; Lu T; Li S; Deng K; Song J
J Imaging Inform Med; 2024 Jun; 37(3):1086-1099. PubMed ID: 38361006
[TBL] [Abstract][Full Text] [Related]
17. Prediction of subsolid pulmonary nodule growth rate using radiomics.
Ma ZJ; Ma ZX; Sun YL; Li C; Jin L; Gao P; Li C; Li M
BMC Med Imaging; 2023 Nov; 23(1):177. PubMed ID: 37936095
[TBL] [Abstract][Full Text] [Related]
18. A Computed Tomography-Derived Radiomics Approach for Predicting Uncommon EGFR Mutation in Patients With NSCLC.
Chen W; Hua Y; Mao D; Wu H; Tan M; Ma W; Huang X; Lu J; Li C; Li M
Front Oncol; 2021; 11():722106. PubMed ID: 34976788
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.
Li T; Liu J; Zhou Y; Huang S; Wang D; Chen J; Fu Y; He P
Cancer Med; 2024 May; 13(10):e7227. PubMed ID: 38770632
[TBL] [Abstract][Full Text] [Related]
20. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]